Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

AvevoRx Partners with Leading Non-Profit Oley Foundation to Provide Education, Specialized Home-Nutrition Support Therapy to Patients Around U.S.


News provided by

AvevoRx

May 05, 2025, 06:00 ET

Share this article

Share toX

Share this article

Share toX

AvevoRx is an independent provider of specialty infusion pharmacy and infusion care services
AvevoRx is an independent provider of specialty infusion pharmacy and infusion care services

Corporate sponsorship package among the latest AvevoRx initiative expanding company's national reach to patients requiring critical home parenteral nutrition services while at home

GREENSBORO, N.C., May 5, 2025 /PRNewswire-PRWeb/ -- AvevoRx, a leading national, independent provider of specialty infusion pharmacy services, announced today a partnership with The Oley Foundation to help support thousands of individuals around the country requiring specialized home parenteral nutrition services.

AvevoRx's corporate sponsorship — part of its ongoing national effort to provide home nutrition support services for complex gastrointestinal conditions — will further Oley's mission of providing education, community, innovation, and other resources in the home nutrition support space. AvevoRx is working with the nonprofit organization, founded in 1983, to determine where its $25,000 contribution will be utilized over the next year.

"For decades, The Oley Foundation has been the go-to national resource for patients, along with their families and caregivers, struggling to address chronic and acute home-nutrition needs," said Eric Hill, co-founder at AvevoRx.

Post this

"For decades, The Oley Foundation has been the go-to national resource for patients, along with their families and caregivers, struggling to address chronic and acute home-nutrition needs," said Eric Hill, co-founder at AvevoRx. "It's the perfect match to help us reach an even greater number of patients while supporting the organization's magnificent mission."

Nearly 500,000 Americans receive some kind of specialized nutrition services at home — whether administered through IV or feeding tubes — according to recent studies, a number that is expected to rise dramatically over the next few years. The Oley Foundation CEO Beth Gore, Ph.D., believes recent shortages in home nutrition providers, combined with rising uncertainty in Medicaid and private-insurance coverage options, are making it increasingly difficult for patients to receive the critical care they need.

"This is a pivotal time for home-nutrition patients seeking access to reliable medical information and the specialized care essential to living long, healthy and productive lives," stated Gore, a long-time patient-safety advocate who named CEO at The Oley Foundation two years ago.

Gore added that 100% of corporate contributions to The Oley Foundation go directly toward patient care, a critical benefit given the numerous cost challenges facing today's home-nutrition patient, including recent tariff policy changes that have negative impacts on industry supply chains. "We're immensely appreciative of AvevoRx's support and look forward to partnering with their team on serving our members and their families in the coming year," Gore continued.

AvevoRx's partnership with Oley is just the latest development that underscores the company's commitment to supporting patients with gastrointestinal disorders requiring long-term therapy. Last summer, Katie Hall, RD, CNSC, was named National Director of AvevoRx Nutrition, bringing with her some 22 years of experience in home infusion and metabolic support, many of them in collaboration with various AvevoRx's executive team members.

Since that time, Hall has helped to deliver on the company's ambitious goal of creating a cohesive, patient-centered Home Parenteral Nutrition (HPN) program by leading a host of clinical- and capital-infrastructure investments — including onboarding board certified dietitians, nurses, pharmacists and advocates specializing in home nutrition support, as well as making major upgrades to its clean room facility in California.

The next milestone in AvevoRx's aggressive expansion in the parenteral nutrition space will be this summer, when Hall and her team open a second state-of-the-art pharmaceutical clean room, near the company's central North Carolina headquarters. The USP 897 compliant facility will enable AvevoRx to prepare, ship, and administer customized parenteral nutrition solutions to complex GI patients, making it the first company of its kind to serve all U.S. markets.

"We're well on our way to building the largest and most sought-after clinically driven Home TPN program in the country," stated Hall, who's led AvevoRx's ongoing collaboration with The Oley Foundation and its leadership team. "Our partnership with Oley represents a critical step in that growth. We're thrilled to play a role in their unrivaled commitment to patient safety, health and quality of life."

AvevoRx began as a startup in Greensboro, N.C., founded by a team of industry veterans with 130 years of combined experience. By November of that year, it acquired Mid Valley Health Services, a long-established infusion company based in Modesto, Calif. In September 2022, AvevoRx entered an agreement to acquire Access to Care, LLC, an independent home infusion pharmacy in Muncie, Ind. Today, both companies operate under the AvevoRx name.

More information on the company and its investment in specialized home-nutrition therapy, as well as its significant financial growth, is available at AvevoRx.com.

About AvevoRx

AvevoRx is a national, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients with complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies on a regional basis for patients with short-term therapeutic needs. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn.

About The Oley Foundation

The Oley Foundation is a non-profit home nutrition therapy community and advocacy group. The organization's mission is to enrich the lives of those living with home IV nutrition or tube feeding through advocacy, education, community and innovation. The Oley Foundation envisions a world where patients are united, supported and empowered to thrive on home nutrition support. More information is available at www.oley.org.

Media Contact
Richard Kendall, AvevoRx, 1 6193462084, [email protected], www.avevorx.com

SOURCE AvevoRx

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.